Business Context and Reporting Period
DarioHealth Corp. (formerly LabStyle Innovations Corp.) filed a Form 8-K on July 28, 2016, reporting events occurring on July 23, 2016. The Company is incorporated in Delaware and headquartered in Caesarea, Israel.
Key Financial Metrics
This filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The report focuses exclusively on a specific contractual amendment regarding investor warrants.
Material Changes
The Company entered into Warrant Amendment Agreements with substantially all investors from a private placement closed in July and August 2015. The material changes to the Existing Warrants include:
- Exercise Price Adjustment: Increased from $6.30 to $6.66.
- Expiration Date Extension: Extended by one year from original dates ranging between July 23, 2016, and August 28, 2016.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of general business risks. The amendment was executed at the request of the Buyers. The text notes that the description of the agreement is brief and qualified by reference to the full Exhibit 10.1.
Investor Verification Checklist
- Verify the total number of warrants affected by the price increase and extension.
- Review Exhibit 10.1 for any additional covenants or conditions attached to the amendment.
- Confirm the dilution impact of the new $6.66 exercise price relative to the current market price.
- Check subsequent filings for any further modifications to the warrant terms.